CompletedNCT00942981
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Observational studyAges 18–90United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 90 years.
- Listed locations
- Bethesda, United StatesSee all locations and recruitment
- Activities
- Medication exposure observed; not assigned by the study
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: November 13, 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 283
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 90 Years
- Official registry ID
- NCT00942981
- Official title
Show the full official title
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Recruitment & locations
CompletedBethesda
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including PET.
Who was this study for?
Listed age limits: 18 years to 90 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
A Study of Pregnant and Postpartum Women With and Without Mood Disorders